| Affiliation: | 1. Nippon Boehringer Ingelheim Co., Ltd., 6-7-5 Minatojima Minamimachi Chuo-ku Kobe Hyogo, 650-0047, Japan;2. Faculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama Funabashi Chiba, 274-8510, Japan;3. Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr. 65, 88400 Biberach a.d. Riss, Germany;4. Institute of Medicinal Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, 142-8501 Tokyo, Japan;1. UGC-Centre of Excellence in Applications of Nanomaterials, Nanoparticles and Nanocomposites, Panjab University, Chandigarh 160 014, India;2. Division of Pharmaceutics, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Studies, Panjab University, Chandigarh 160 014, India;1. Department of Pharmaceutics, College of Pharmacy, Shandong University, Jinan 250012, PR China;2. School of Pharmaceutical Sciences and Center for Pharmaceutical Research & Drug Delivery Systems, Shandong University, Jinan 250012, PR China;3. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100083, PR China;1. School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, PR China;2. Shanghai Institute of Pharmaceutical Industry, 1111 Zhongshan beiyi Road, Shanghai 200437, PR China;1. Department of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia;2. Division of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, FI-00014, P.O. Box 56 (Viikinkaari 5E), Finland;3. Institute of Physics, Faculty of Science and Technology, University of Tartu, Riia 142, 51014 Tartu, Estonia |
